Last update 29 Sep 2025

NLRP3 inhibitors(Smith, Gambrell & Russell)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Compound 7b(Smith, Gambrell & Russell)
Target
NLRP3
Action
inhibitors
Mechanism
NLRP3 inhibitors(NACHT, LRR and PYD domains-containing protein 3 inhibitors)
Therapeutic Areas
Immune System DiseasesRespiratory Diseases
Active Indication
AsthmaPulmonary Disease, Chronic Obstructive
Inactive Indication-
Originator Organization
Smith, Gambrell & Russell LLPSmith, Gambrell & Russell LLP
Active Organization
Smith, Gambrell & Russell LLPSmith, Gambrell & Russell LLP
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with NLRP3 inhibitors(Smith, Gambrell & Russell)
Login to view more data
100 Translational Medicine associated with NLRP3 inhibitors(Smith, Gambrell & Russell)
Login to view more data
100 Patents (Medical) associated with NLRP3 inhibitors(Smith, Gambrell & Russell)
Login to view more data
6
Literatures (Medical) associated with NLRP3 inhibitors(Smith, Gambrell & Russell)
10 Apr 2025ACS Medicinal Chemistry Letters
Novel Compounds as NLRP3 Inhibitors for Treating Asthma or COPD
12 Dec 2024ACS Medicinal Chemistry Letters
Pyridazine Compounds as NLRP3 Inhibitors for Treating Parkinson’s Disease or Frontotemporal Dementia
01 Aug 2023European journal of clinical pharmacology
How to make the best of NLRP3 inhibitors in patients with COVID-19?
100 Deals associated with NLRP3 inhibitors(Smith, Gambrell & Russell)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AsthmaDiscovery
United States
Smith, Gambrell & Russell LLPSmith, Gambrell & Russell LLP
01 Apr 2025
Pulmonary Disease, Chronic ObstructiveDiscovery
United States
Smith, Gambrell & Russell LLPSmith, Gambrell & Russell LLP
01 Apr 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free